They analyzed the expression of three exosomal markers (CD9, CD81, and CD63), showing a mean concentration higher for CD63 and lower for CD9 and CD81 between cancer patients and healthy individuals, although significant statistical differences were observed only for CD81 levels. Here, CD9 is linked to cancer.